Table 3.
Variables | Study population (n = 104) N (%) |
25-OH vitamin D levels** Mean values ± SD (median; min–max) ng/ml |
U, p-value |
---|---|---|---|
Surgical site infection/yes | 9 (8.7%) | 16.4 ± 9.1 (14.3; 5–60.1) | U = 246.000, p = 0.036* |
Surgical site infection/no | 95 (91.3%) | 11.4 ± 7.7 (8.3; 4.5–25.9) | |
Infectious complications/yes | 18 (17.3%) | 16.8 ± 9.4 (14.8; 5–60.1) | U = 515.000, p = 0.026* |
Infectious complications/no | 86 (82.7%) | 12.1 ± 6.2 (11.1; 4.5–25.9) | |
Postoperative complications/yes | 25 (24%) | 16.8 ± 9.7 (14.6; 5–60.1) | U = 757.000, p = 0.08 |
Postoperative complications/no | 79 (76%) | 13.1 ± 6.2 (11.9; 4.5–25.9) |
* Variables with p value < 0.05
**In this hypothesis testing table, the power analysis was 75.3%. To obtain a significant difference between categorical variables of vitamin D levels and infectious complications, the number needed to be treated was 6789. To that end, we chose to use scale variables for vitamin D levels to demonstrate the relation with infectious complications. Since it gives the reason of using vitamin D levels as scale variables while analysing its relation to infectious complications (which is the main outcome of the study), not as subgroups of vitamin D levels